374 related articles for article (PubMed ID: 25907331)
1. A comprehensive glycome profiling of Huntington's disease transgenic mice.
Gizaw ST; Koda T; Amano M; Kamimura K; Ohashi T; Hinou H; Nishimura S
Biochim Biophys Acta; 2015 Sep; 1850(9):1704-18. PubMed ID: 25907331
[TBL] [Abstract][Full Text] [Related]
2. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery.
Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S
Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of total serum glycome in human and mouse.
Yoshida Y; Furukawa JI; Naito S; Higashino K; Numata Y; Shinohara Y
Proteomics; 2016 Nov; 16(21):2747-2758. PubMed ID: 27601404
[TBL] [Abstract][Full Text] [Related]
4. Large-scale glycomics for discovering cancer-associated N-glycans by integrating glycoblotting and mass spectrometry.
Amano M; Nishimura S
Methods Enzymol; 2010; 478():109-25. PubMed ID: 20816476
[TBL] [Abstract][Full Text] [Related]
5. Tear N-glycomics in vernal and atopic keratoconjunctivitis.
Messina A; Palmigiano A; Tosto C; Romeo DA; Sturiale L; Garozzo D; Leonardi A
Allergy; 2021 Aug; 76(8):2500-2509. PubMed ID: 33583051
[TBL] [Abstract][Full Text] [Related]
6. Region-Specific Cell Membrane N-Glycome of Functional Mouse Brain Areas Revealed by nanoLC-MS Analysis.
Barboza M; Solakyildirim K; Knotts TA; Luke J; Gareau MG; Raybould HE; Lebrilla CB
Mol Cell Proteomics; 2021; 20():100130. PubMed ID: 34358619
[TBL] [Abstract][Full Text] [Related]
7. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the human seminal plasma glycome reveals the presence of immunomodulatory carbohydrate functional groups.
Pang PC; Tissot B; Drobnis EZ; Morris HR; Dell A; Clark GF
J Proteome Res; 2009 Nov; 8(11):4906-15. PubMed ID: 19606896
[TBL] [Abstract][Full Text] [Related]
9. Qualitative and quantitative cellular glycomics of glycosphingolipids based on rhodococcal endoglycosylceramidase-assisted glycan cleavage, glycoblotting-assisted sample preparation, and matrix-assisted laser desorption ionization tandem time-of-flight mass spectrometry analysis.
Fujitani N; Takegawa Y; Ishibashi Y; Araki K; Furukawa JI; Mitsutake S; Igarashi Y; Ito M; Shinohara Y
J Biol Chem; 2011 Dec; 286(48):41669-41679. PubMed ID: 21965662
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional glycosphingolipidomics by glycoblotting with an aminooxy-functionalized gold nanoparticle.
Nagahori N; Abe M; Nishimura S
Biochemistry; 2009 Jan; 48(3):583-94. PubMed ID: 19117481
[TBL] [Abstract][Full Text] [Related]
11. Plasma N-Glycome Signature of Down Syndrome.
Borelli V; Vanhooren V; Lonardi E; Reiding KR; Capri M; Libert C; Garagnani P; Salvioli S; Franceschi C; Wuhrer M
J Proteome Res; 2015 Oct; 14(10):4232-45. PubMed ID: 26334954
[TBL] [Abstract][Full Text] [Related]
12. Spatially-resolved exploration of the mouse brain glycome by tissue glyco-capture (TGC) and nano-LC/MS.
Ji IJ; Hua S; Shin DH; Seo N; Hwang JY; Jang IS; Kang MG; Choi JS; An HJ
Anal Chem; 2015 Mar; 87(5):2869-77. PubMed ID: 25643168
[TBL] [Abstract][Full Text] [Related]
13. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
[TBL] [Abstract][Full Text] [Related]
14. Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice.
Zajac MS; Pang TY; Wong N; Weinrich B; Leang LS; Craig JM; Saffery R; Hannan AJ
Hippocampus; 2010 May; 20(5):621-36. PubMed ID: 19499586
[TBL] [Abstract][Full Text] [Related]
15. Quantifying Protein-Specific N-Glycome Profiles by Focused Protein and Immunoprecipitation Glycomics.
Kobayashi T; Ogawa K; Furukawa JI; Hanamatsu H; Hato M; Yoshinaga T; Morikawa K; Suda G; Sho T; Nakai M; Higashino K; Numata Y; Shinohara Y; Sakamoto N
J Proteome Res; 2019 Aug; 18(8):3133-3141. PubMed ID: 31266306
[TBL] [Abstract][Full Text] [Related]
16. Stable isotopic labeling-based quantitative targeted glycomics (i-QTaG).
Kim KJ; Kim YW; Kim YG; Park HM; Jin JM; Hwan Kim Y; Yang YH; Kyu Lee J; Chung J; Lee SG; Saghatelian A
Biotechnol Prog; 2015; 31(3):840-8. PubMed ID: 25832445
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar lipid differences between R6/1 transgenic mice and humans with Huntington's disease.
Denny CA; Desplats PA; Thomas EA; Seyfried TN
J Neurochem; 2010 Nov; 115(3):748-58. PubMed ID: 20731757
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment.
Wagner L; Björkqvist M; Lundh SH; Wolf R; Börgel A; Schlenzig D; Ludwig HH; Rahfeld JU; Leavitt B; Demuth HU; Petersén Å; von Hörsten S
J Neurochem; 2016 Jun; 137(5):820-37. PubMed ID: 27016395
[TBL] [Abstract][Full Text] [Related]
19. Comparative Glycomics of Fat Globule Membrane Glycoconjugates from Buffalo (Bubalus bubalis) Milk and Colostrum.
Brijesha N; Nishimura SI; Aparna HS
J Agric Food Chem; 2017 Mar; 65(8):1496-1506. PubMed ID: 28145111
[TBL] [Abstract][Full Text] [Related]
20. Dried blood spot N-glycome analysis by MALDI mass spectrometry.
Vreeker GCM; Bladergroen MR; Nicolardi S; Mesker WE; Tollenaar RAEM; van der Burgt YEM; Wuhrer M
Talanta; 2019 Dec; 205():120104. PubMed ID: 31450448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
